Writing for Medications- Clinical Pearls
|
|
- Dominick Sullivan
- 6 years ago
- Views:
Transcription
1 Writing for Medications- Clinical Pearls Dr Pete Antonopoulos PharmD Clinical Pharmacist Specialist Stroger Hospital of Cook County UIC Assistant Clinical Professor
2 Inpatients Prescriptions Cerner PowerChart (Computer Order Entry COE) Exceptions Chemo, TPN, PCA orders Write Legibly (Pt name, signature, DX, ALL) If BSA or weight based dosing (write info)
3 Cerner PowerChart Ordering medications in PowerChart: Quick type first 3 letters Drugs listed by generic names Depakote = Divalproex sodium
4 NARCOTIC C 3-5 DEA number (attendings or if a resident has a perm license) Hand printed signature of MD with DEA C 3-5: = codeine, hydrocodone, alprazolam, phenobarbital, zolpidem, Lomotil (diphenoxylate) and Tramadol Write out quantity in name & number (#fifty (#50))
5 C-2 s The Big Ones Separate Prescription C-2 s only! i.e.morphine goes on a separate prescription sheet Physician s original signature Write quantity (sixty and 60) No refills!!! No faxes!!! No changes!!! (no exceptions) Morphine IR=immediate release Q2-4h Morphine SR= sustained release Q12h Fentanyl patch Q 72 hr
6 Medication Safety 5 Rights
7 Medication Errors Common occurrence and continue to be a problem in the health care industry Annual cost of drug-related morbidity and mortality is nearly $177 billion in the United States Approximately 7,000 deaths occur each year 1 of every 5 doses given in hospitals FDA :at least one death per day and 1.3 million people are injured each year due to medication errors
8 Medication Errors ~ 15% of the medication error occur from illegible handwriting problems with leading and trailing zeros, misinterpreted abbreviations, and incomplete medication orders. NEVER EVENTS GUESSING WEIGHTS, DOSING Allergies Extended Release vs Regular Release
9 ADJUSTMENTS DRUGS ARE METABOLIZED / ELIMINATED EITHER RENALLY OR HEPATICALLY ADJUST FOR EITHER OR BOTH RENAL AND HEPATIC INSUFFICIENCY CROCK-KOFF-GAULT EQUATION MDRD CHILDS-PUGH ELDERLY GENDER NATIONALITY
10 DRUG INTERACTIONS CYTOCHROME P-450 P-GLYCOPROTEINS DRUGS WITH MULTIPLE INTERACTIONS: HIV MEDS, COUMADIN, AMIODARONE, DIGOXIN, ANTIEPILEPTICS, ETC USE LEXICOMP IN UP-TO-DATE AND LOOK AT CERNER POP-UPS
11 Medication safety: Look Alike Sound Alike Drug names can often sound similar or appear similar. The appearance of the products can look similar enough to cause confusion. These can easily be confused contributing to adverse medication events. Stop and Verify spelling, Readback!
12 High Alert Medications The top 5 high-alert medications Insulin Opiates and narcotics Injectable potassium Anticoagulants (heparin, LMWH, warfarin, etc) Sodium chloride solutions above 0.9 percent
13 COMMON ERRORS METOPROLOL / TOPROL _ DAILY INSTEAD: METOPROLOL/TOPROL XL DECIMAL ERRORS COUMADIN 1.0MG GUESSING WEIGHTS WRONG PATIENT WRONG DRUG ANTICOAGULATION INSULIN ALLERGIES
14 Ulcer PROPHYLAXIS NOT NEEDED FOR EVERYONE INTUBATED ICU PATIENTS AND COAGULOPATHY PATIENTS START WITH H-2 BLOCKERS FIRST REMEMBER TO DISCONTINUE UPON DISCHARGE!! Prophylaxis can INCREASE PNEUMONIA RISK ALTERS MEDICATION/NUTRITION ABSORPTION
15 PROTOCOLS ANTICOAGULATION HEPARIN ENOXAPARIN INSULIN MED/SURG ICU ID GUIDELINES CONTRAST INDUCED NEPROPATHY CLOPIDOGREL SKIN BREAKDOWN
16 DVT PROPHYLAXIS DVT RISK ASSESSMENT ON EVERY PATIENT!!! PREFERRED PROPHYLAXIS: HEPARIN 5000 UNITS HEPARIN Q8 HRS (MOD- HIGH RISK) HEPARIN Q8 = ENOXAPARIN 40mg qd HIGH RISK (Intubated, CHF, COPD, MI, STROKE, CANCER, hx DVT/PE, SURGERY, etc) See DVT Guidelines
17 Anticoagulation Enoxaparin Actual bodyweight up to 200 kg 1.5 mg/kg daily for cancer, DVT, small PE Q12 hr dosing for other uses Fondaparinux Actual Body Weight 5-10 mg sc daily Dalteparin Actual Body Weight (100 Units/kg Q12 hr) Coumadin Clinic IRIS referral ph #4-6327
18 Anticoagulation Heparin (Based on IBW) DVT/PE/Bridging Dosing 80 u/kg bolus Max 10,000 units 18 u/kg/hr based on ideal body weight Max 2,000 units/hr initial dose, titrate up or down based on aptt aptt 2-3x baseline (60-90)
19 Contrast Renal Protection SCr 1.1 and above Stop diuretics, metformin Sodium bicarbonate drip in D5W or sterile water if diabetic 3ml/kg bolus over 1 hr before procedure 1ml/kg/hr during procedure and for 6 hr later If patient fluid overloaded check with attending Acetylcysteine 20% for renal protection 1200 mg po with cold juice night before, morning before and 2 doses after procedure separated by 4-6 hrs
20 New Changes Additions Carvedilol Q12hr Isosorbide mononitrate once daily Simvastatin all doses 5-80 mg qhs Amlodipine 5-20mg once daily Equivalence to Nifedipine Nifedipine 30mg = Amlodipine 5 mg Nifedipine 60mg = Amlodipine 10 mg Nifedipine 90mg = Amlodipine 20 mg
21 MAP Medication Assistance Program Helps patient apply for free medication from manufacturers Patients on costly drugs with no insurance See website on-line under Pharmacy in Departments sections (on intranet) List of pharmacies in area with low cost generics Monina Quindipan, PharmD, MAP Coordinator,
22 Services Medication Services available only for Cook County Residents. See list of zip-codes on-line. Non-Cook residents should contact local County Department of Health or MAP Service fee of $3 per medication up to $10 max per visit apply. Currently waived for LOL-H, Medicare, Medicaid If unable to pay patient should go to Finance Department at Room 1290 to apply for LOL-H
23 MEDICATION TIMING COUMADIN DOSED AT BEDTIME STATINS DOSED AT BEDTIME DRUGS THAT HAVE TO BE DOSED Q_HOURLY: ANTIBIOTICS, HEPARIN, ENOXAPARIN, ALL HYPERTENSION DRUGS EXCEPT ISOSORBIDE BID= 9AM/5PM TID= 9AM/1PM/5PM QID= 9AM/1PM/5PM/9PM QD=9AM Calcium before meals to bind Phosphorus Coumadin and NSAIDS, ANTIBIOTICS
24 Intern Survival Guide ID Guidelines on-line Diabetes hospital Guidelines Anticoagulation Guidelines
25 Pharmacy Numbers Inpatient Pharmacy Outpatient Stroger Pharmacy Pharmacy Manager Discharge Pharmacy Clinical On-call Ask for on-call Administrator Fantus Clinic Pharmacy / Pharmacy Manager
26 PHARMACY SERVICES NON-FORMULARY SERVICE PAGER: Inpt Pharmacy Outpt 4-16 PROTOCOLS/GUIDELINES/PAGER: GO TO MAIN CCH WEBPAGE AND UNDER DEPARTMENTS CLICK PHARMACY FORMUALRY PUBLISHED ONLINE ADR (Adverse Drug Reaction) NOT SURE? JUST ASK!!!!
27 Summary 5 rights Outpatient Rx = good handwriting Know Schedule for BID, TID If you are not sure, ASK!
Drug Prescribing. Ravi Menon
Drug Prescribing Ravi Menon Introduction Approximately 7,000 individual drug doses are administered each day in a 'typical' NHS hospital, 70% of which are prescribed by first year graduates and senior
More informationClinical Guideline for Anticoagulation in VTE
Clinical Guideline for Anticoagulation in VTE These clinical guidelines are intended to provide evidence-based recommendations regarding the anticoagulation in patients with DVT and PE. Please note that
More informationHeparin Drip. Ordering
Heparin Drip Ordering Nurse entering of Heparin drip orders for physicians should only occur in situations when it is not feasible for the physician to enter orders directly Select the Heparin IV Drip
More informationHigh Alert Medications in the long-term care setting. Carrie Allen PharmD, CGP, BCPS, CCHP
High Alert Medications in the long-term care setting Carrie Allen PharmD, CGP, BCPS, CCHP Who does this involve? Nurses Medication aides Pharmacies/pharmacists Medical Records and Data Entry Personnel
More informationWMC PHARMACY ANTICOAGULATION PROTOCOL Current Revision: July 2017 GENERAL ORDER PROCESSING AND MANAGEMENT
WMC PHARMACY ANTICOAGULATION PROTOCOL Current Revision: July 2017 GENERAL ORDER PROCESSING AND MANAGEMENT - Entering orders for anticoagulation in Cerner Providers will enter individual orders (oneoffs)
More informationFamily Medicine Clinical Pharmacy Forum Vol. 4, Issue 5 (September/October 2008)
1 Family Medicine Clinical Pharmacy Forum Vol. 4, Issue 5 (September/October 2008) Family Medicine Clinical Pharmacy Forum is a brief bi-monthly publication from the Family Medicine clinical pharmacists
More informationEnsuring Safety of Anticoagulation Therapy
Ensuring Safety of Anticoagulation Therapy Abha Agrawal, MD, FACP Chief Medical Officer Kings County Hospital Clinical Associate Dean SUNY Downstate College of Medicine Brooklyn, NY NYACP Webinar April
More informationLumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.
Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical
More informationADULT POST NEUROLOGIC INTERVENTION ORDERS 2 of 4
9 Actual 9 Estimated DOWNTIME INTERVENTION 1 of 4 Weight kg 9 Actual 9 Estimated Height cm ALLERGIES: REFER TO ALLERGY PROFILE/ POWERCHART Admit to Dr.: Bed Type: Dx: ( ) Check, circle and/or fill in all
More informationSpecial Situations 1
Special Situations 1 Outline Continuous Nutrition Tube feeds TPN Steroids Pumps Perioperative BG Control 2 Patient receiving continuous TF or TPN Continuous nutrition coverage options: Analog q4hr Regular
More informationPathology Service User Guide Haematology
Pathology Service User Guide Haematology St Richard s This section of the Pathology Service User Guide includes: Anticoagulant Therapy Information about the Anticoagulant Clinic Low Molecular Weight Heparin
More informationIs it so small a thing To have enjoy d the sun, To have lived light in the spring, To have loved, to have thought, to have done e133
chapter NINE costs of chronic kidney disease Is it so small a thing To have enjoy d the sun, To have lived light in the spring, To have loved, to have thought, to have done Matthew Arnold, From the Hymn
More informationEstimating Medicaid Costs for Cardiovascular Disease: A Claims-based Approach
Estimating Medicaid Costs for Cardiovascular Disease: A Claims-based Approach Presented by Susan G. Haber, Sc.D 1 ; Boyd H. Gilman, Ph.D. 1 1 RTI International Presented at The 133rd Annual Meeting of
More informationPhysician Orders ADULT: PCI Post Procedure Plan
Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase Phase: PCI Post Procedure Phase, When to Initiate: Initiate Powerplan Phase Phase: Post Cath/PCI Hydration Protocol Phase,
More informationHip Hemiarthroplasty Post Op Version 2 4/20/17
Patient Name: Diagnosis: Allergies with reaction type: Hip Hemiarthroplasty Post Op Version 2 4/20/17 Patient Placement General Diagnosis/Procedure: Preferred Location/Unit Ortho/Neuro PCU ICU General
More informationTHE QUEEN ELIZABETH HOSPITAL The Do Not Use List aka ISMP s List of Error-Prone Abbreviations, Symbols, and Dose Designations
Abbreviation to be avoided Potential Problem µg Microgram Mistaken for mg (milligrams) resulting in one thousand fold dosing overdose. IU International Mistaken for IV (intravenous) or 10 unit (ten). A.S.,
More informationa. A pharmacist may order a baseline SCr per protocol
UNITYPOINT HEALTH - MARSHALLTOWN Marshalltown, Iowa PHARMACY POLICY AND PROCEDURE Subject: Anticoagulant Therapy Per Practice Protocol (Formerly Anticoagulant therapy #NPSG.03.05.01) Inpatient Warfarin
More informationIncorporated Dosing Guidelines: Intravenous Heparin Therapy Initial Dose
Intravenous Heparin Therapy Initial Dose (Max Dose) IV Infusion Rate IV Infusion Rate (Max Dose) Lab Tests High Dose 80 units/kg 8,000 units 18 units/kg/hr 1,800 units/hr Intermediate Dose 5,000 units
More informationVenous Thromboembolism National Hospital Inpatient Quality Measures
Venous Thromboembolism National Hospital Inpatient Quality Measures Presentation Overview Review venous thromboembolism as a new mandatory measure set Outline measures with exclusions and documentation
More informationSpecial instructions: Enter both orders in sequence without discontinuing 1st order.
Appendix 1. Test Case Scenario List and Instructions Test Case 1: 1. Enter patient allergy for Lisinopril in test patient s chart. 2. Enter order for Captopril 12.5 mg PO TID. Special instructions: If
More informationSample. Fractured Hip Post-Operative Orders. Legend < Mandatory fields o Optional fields. Height Allergies: List or o Up to date in electronic system
Legend Mandatory fields o Optional fields Height Allergies: List or o Up to date in electronic system cm Weight Diagnosis kg Date (yyyy-mon-dd) Time (hh:mm) Anticipated Date Of Discharge (ADOD) o Greater
More informationMyocardial Infarction Order Set
Myocardial Infarcti Order Set Date Time 1. [ ] Inpatient: [ ] CCU [ ] PCU [ ] ICU 2. Diagnosis: Admit to: Dr. 3. Code Status: [ ] See Completed Code Sheet * ote: o Code verbal order may ly be taken in
More informationNuts for Neuro and why I hate EMR
Nuts for Neuro and why I hate EMR Roberta S Rose, DO private practice in General neurology Staff physician: IRMC and SRMC I have no disclosures, I m just a working stiff Stroke overview: 2018 Guidelines
More informationI. UNIFORM FORMULARY REVIEW PROCESS
DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. UNIFORM FORMULARY REVIEW PROCESS Under 10 United States Code 1074g, as implemented
More informationConflict of Interest Declaration. High Risk Medications in the Hospital Pharmacy. According to. Learning Objectives. Medication Safety Organizations
Conflict of Interest Declaration High Risk Medications in the Hospital Pharmacy None to disclose Monika Gil, Pharm.D. Clinical Staff Pharmacist Rush University Medical Center Chicago, IL Learning Objectives
More informationAppendix IV - Prescribing Guidance for Apixaban
Appendix IV - Prescribing Guidance for Apixaban Patient Factors Dose of Apixaban If your patient has any of the following MAJOR risk factors: Hypersensitivity to the active substance or to any of the excipients
More informationDavis s Drug Guide Scavenger Hunt 15 th Edition
Davis s Drug Guide Scavenger Hunt 15 th Edition This handout is designed to assist you in locating information in the Davis s Drug Guide. Take advantage of the many resources in this text!! Locate the
More informationDo Not Use Abbreviations
Do Not Use Abbreviations The Institute for Safe Medication Practice (ISMP) and the Joint Commission (JACHO) have each developed a list of dangerous abbreviations. The list includes abbreviations considered
More informationNEWSLETTER DUE CARE PROGRAM. WINTER 2014 Summer 2015 COMMONLY ASKED QUESTION:
DUE CARE PROGRAM NEWSLETTER WINTER 2014 Summer 2015 Lisa Sather, RPh DUR Coordinator Mountain-Pacific Quality Health 3404 Cooney Drive Helena, MT 59602 406-457-5818 The DUE CARE PROGRAM, administered by
More information6 th Floor and 7 East Nurses Guide Intravenous Drip List Approved for RN Administration University of Kentucky Chandler Medical Center
RATE Abciximab (Reopro) Alteplase (tpa, Activase) All units 6S and 6W ONLY Platelet aggregation inhibitor Thrombolytic agent Bolus: 0.25 mg/kg IV over 5 min Infusion: 0.125 0.9 mg/kg (max 90 mg); 10% of
More informationHeparin-Induced Thrombocytopenia. Steven Baroletti, PharmD., M.B.A., BCPS Brigham and Women s Hospital
Heparin-Induced Thrombocytopenia Steven Baroletti, PharmD., M.B.A., BCPS Brigham and Women s Hospital Heparin-induced thrombocytopenia (HIT) A serious concern associated with thrombosis development following
More informationHot Topics: Transitions of Care
Our quarterly newsletter is a great way to stay up-to-date on emerging clinical information, medication safety issues, and Larkin s Hospital medication policies and procedures. Hot Topics: Transitions
More informationPAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose
NON-OPIOID SHORT-ACTING LONG-ACTING **** O PAIN TREATMENT TABLES Analgesics NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose Tramadol 50 mg Ultram Every 4 hours 1-2 tabs,
More informationInitials * Page 1 of 6. (place patient label here) Patient Name: Diagnosis: Allergies with reaction type:
Patient Name: Diagnosis: Allergies with reaction type: Orthopedic Upper Ext Post Op Version 3 4/20/17 Patient Placement General Diagnosis/Procedure: Preferred Location/Unit Ortho/Neuro General Medical
More informationPaediatric Prescribing Pocket Guide September 2014 (Version 1)
PAGE 1 Paediatric Prescribing Pocket Guide September 2014 (Version 1) In children, the risk of medication errors is often exacerbated by the need for calculations to determine the dose. Prescribing errors
More informationOutpatient Treatment of Deep Vein Thrombosis with Low Molecular Weight Heparin (LMWH) Clinical Practice Guideline August 2015
Outpatient Treatment of Deep Vein Thrombosis with Low Molecular Weight Heparin (LMWH) Clinical Practice Guideline August 2015 General Principles: There is compelling data in the medical literature to support
More information* * FORM REV. 02/2019 Page 1 of 4. TNKASE (tenecteplase) / ACUTE STEMI ORDERS SCHEDULED MEDICATIONS:
1. Is this a CMS inpatient only procedure? Yes, admit as inpatient, proceed to # 3 No, proceed to # 2 2. Do you expect that the patient s condition will require a hospital stay that will cross two midnights
More informationWelcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1
Welcome Everyone Sign-In Enjoy Breakfast Meet someone new Enter Raffle Pick a team name Please silence phones We start at 8:00am Monitoring, Sick Days, Inpatient Management - Objectives Objectives: Strategies
More informationPhysician Orders ADULT: Atrial Fib/Flutter Plan
Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase Phase: Atrial Fib/Flutter Phase, When to Initiate: Atrial Fib/Flutter Phase Non Categorized Problem: Atrial fibrillation Problem:
More informationShared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins
Tameside Hospital NHS Foundation Trust and NHS Tameside and Glossop Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins Version 5.2 Version: 5.2 Authorised by: Joint Medicines
More information3/19/2012. What is the indication for anticoagulation? Has the patient previously been on warfarin? If so, what % of the time was the INR therapeutic?
Abigail E. Miller, PharmD, BCPS Clinical Specialist, Cardiology University of North Carolina Hospitals I have no personal financial relationships with the manufacturers of the products to disclose. Boehringer
More informationUnit6. Prescriptions. Speaking:Giving A Prescription. Vocabulary: Common Latin Rx Terms. Articles: A Prescription: Understanding.
Unit6 Prescriptions Grammar: The Future: Will\ Going to Expressing the Future in Time Clauses Using the Present Progressive and Simple Present to Express Future Time Future Progressive Speaking:Giving
More informationTechnician Training Tutorial: Dispensing Oral Blood Thinners
(Page 1 of 5) Technician Training Tutorial: Dispensing Oral Blood Thinners Warfarin (Coumadin, Jantoven-U.S., others) is an oral anticoagulant blood thinner used to help prevent blood clots that can lead
More informationGeriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center
Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)
More informationPharmacy Partnership to Improve Patient Outcomes
Pharmacy Partnership to Improve Patient Outcomes Minnesota Rural Health Conference Session 2B Ryan M. Harden, MD MS Kendra Metz, Pharm D Sarah Nelson, MD June 25, 2018 Involved Partners Involved Partners
More informationAdmit date (YYYY/MM/DD): Cardiologist On-Call: Diagnosis: Lab Tests. CBC, Electrolytes, Urea, Creatinine, Glucose, INR, PTT, Urinalysis
of nurse 1. Admit under ward Attending Physician: Dr. Admit date (YYYY/MM/DD): Cardiologist On-Call: Diagnosis: Lab Tests 2. On admission (if not already performed in Emergency Department or in Coronary
More informationPPP 1. Continuation, modification, and discontinuation of a medication
PRESCRIBING POLICIES: 4.7 PHARMACIST AUTHORITY The College of Pharmacists of BC Professional Practice Policy (PPP) 58 Medication Management (Adapting a Prescription) became effective April 1, 2009. The
More informationAnticoagulation therapy : improving processes. Hilary Merrett and Fiona Gale, CHKS 18 th October 2010
Anticoagulation therapy : improving processes using risk management tools Hilary Merrett and Fiona Gale, CHKS 18 th October 2010 Risk management tools and anticoagulation therapy The applicable processes
More informationPharmacotherapy Issues in the Pediatric Population
Pharmacotherapy Issues in the Pediatric Population Continuing Professional Pharmacy Development Dr. Shane Pawluk, PharmD Dr. Andrea Cartwright, PharmD Dr. Maryam Khaja March 26, 2014 Outline Didactic Session
More informationIntrinsic + Common = aptt. Extrinsic + Common = PT. Common Pathway
Anticoagulant Cases 12 11 Intrinsic + Common = aptt 9 8 10 7 4 Extrinsic + Common = PT 5 2 Common Pathway 1 Xa Inhibitors rivaroxaban (Xarelto) apixaban (Eliquis) edoxaban (Savaysa) What is true regarding
More informationAtrial Fibrillation Version 2 11/4/15 This order set must be used with an admission order set if patient not already admitted.
Patient Name: Diagnosis: Allergies with reaction type: Atrial Fibrillation Version 2 11/4/15 This order set must be used with an admission order set if patient not already admitted. Telemetry Medical Telemetry:
More informationPEDIATRIC SPINE SURGERY POST-OP PLAN - Phase:.
- Phase:. PHYSICIAN S Diagnosis Weight Allergies DETAILS Patient Care Patient Activity Bedrest Maintain Surgical Drain Maintain JP Drain, Measure Output q12h, and PRN Convert IV to INT when tolerating
More informationDr. Steve Ligertwood Dr. Roderick Tukker Dr. David Wilton
Dr. Steve Ligertwood Hospitalist Royal Columbian Hospital Regional Department Head-Hospitalist for Fraser Health Authority Project Lead BC Hospitalist VTE Collaborative Clinical Instructor, UBC School
More informationMedications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy.
Medications Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy. What do I need to know about medications after my heart attack? When you
More informationDVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)
DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) Introduction VTE (DVT/PE) is an important complication in hospitalized patients Hospitalization for acute medical illness
More informationChapter 1 The Reversing Agents
Available Strategies to Reverse Anticoagulant Medications Michael L. Smith, Pharm. D., BCPS, CACP East Region Pharmacy Clinical Manager Hartford HealthCare Objectives: Describe the pharmacological agents
More informationChange from lovenox to pradaxa
P ford residence southampton, ny Change from lovenox to pradaxa 14-11-2017 We wanted to put out a friendly reminder that the Ask 3 Teach 3 (A3T3) initiative is indeed full swing. This is an multidisciplinary
More information2.5 Other Hematology Consult:
The Warfarin Order Sheet has been approved by the P & T committee to be implemented by pharmacists. These orders are not used to treat patients with serious hemorrhagic complications. WARFARIN TARGET INR
More informationCARDIAC REHABILITATION PROGRAMME:- MEDICATION
CARDIAC REHABILITATION PROGRAMME:- MEDICATION AIM OF THIS SESSION Understand the reasons for taking your medications, Discuss the common side effects associated with these medications - knowing when to
More informationImproving Glycemic Control in the Critical Care
Improving Glycemic Control in the Critical Care Setting /Hospitalists Outline Review current guidelines Review current glycemic targets DKA Treatment Building a perfect glycemic control protocol Transition
More informationPharmacy Leadership, Touching all the Bases
Pharmacy Leadership, Touching all the Bases John Fanikos, R.Ph., M.B.A. Executive Director of Pharmacy Brigham and Women s Hospital November 16 th, 2018 Abu Dhabi, UAE Objectives Review important characteristics
More informationAssessment. Consults & Referrals
University of Virginia Health System Clinical Pathway: Whipple Enhanced Recovery After () LOS: 4-5 days Date of Origin/Revision: June 29, 2016/September 6, 2017/January 31, 2018 : SAS : : : D1 D2 D 3/
More informationOrthopedic Admission Hip Fracture Version 2 1/25/2017
Patient Name: Initial each page and Sign/Date/Time last page Diagnosis: Allergies with reaction type: Orthopedic Admission Hip Fracture Version 2 1/25/2017 Patient Placement Patient Status If the physician
More informationNews & Views. Antipsychotics on Maryland Medicaid PDL and Coverage of a 30-day Emergency Supply of Atypical Antipsychotics
Maryland Medicaid Pharmacy Program News & Views February 2011 Maryland Department of Health and Mental Hygiene /Office of Systems, Operations and Pharmacy Antipsychotics on Maryland Medicaid PDL and Coverage
More informationMedication Safety Presentation
Appendix E Aid 1: Sample Event Poster Medication Safety Presentation Do YOU know your role on the healthcare team? Do YOU know the questions to ask your pharmacist? Do YOU know safe medication practices?
More informationWhat s new with DOACs? Defining place in therapy for edoxaban &
What s new with DOACs? Defining place in therapy for edoxaban & Use of DOACs in cardioversion Caitlin M. Gibson, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy University of North Texas
More informationEXTENDING VTE PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS
EXTENDING VTE PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS Samuel Z. Goldhaber, MD Director, VTE Research Group Cardiovascular Division Brigham and Women s Hospital Professor of Medicine Harvard Medical
More informationProtocols for the Management of Cardiac Conditions. By Pam Bayles, RN, BSN
Protocols for the Management of Cardiac Conditions By Pam Bayles, RN, BSN Deaths in Thousands 1,000 800 600 400 200 0 00 10 20 30 40 50 60 70 80 90 00 06 Years Deaths from diseases of the heart (United
More informationPhysician/Clinic Collaborative Practice Agreement
Physician/Clinic Collaborative Practice Agreement Effective October 1, 2010, Connecticut Senate Bill 428 (PA 10-117) extends to all settings and medical conditions the opportunity for licensed pharmacists
More informationFailure Modes Effects Analysis of Morphine Prescribing
Failure Modes Effects Analysis of Morphine Prescribing Hilary Writer MD FRCPC Elaine Wong BScPhm CPSI Patient Safety and Quality Improvement Forum,14 April 2010 Outline Rationale Medication Incidents with
More informationPhysician Orders LEB PICU Status Epilepticus Plan. [ ] No known allergies
Height: cm Weight: kg Allergies: [ ] No known allergies [ ] Initiate Powerplan Phase T;N, Phase: LEB PICU Admit Phase Admission/Transfer/Discharge [ ] Admit Patient to Dr. [ ] Admit Status: [ ] Inpatient
More informationPHARMACY Section 9. Overview. Preferred Drug List. Additions and Exceptions to the Preferred Drug List
Overview The management of outpatient prescription drugs is an integral part of the medical management program to improve the health and well-being of our members. Prescriber and member involvement is
More informationManaging Narcotics on Workers Comp Claims. Presented By: Craig S. Stern, PharmD, MBA President Pro Pharma Pharmaceutical Consultants, Inc.
Managing Narcotics on Workers Comp Claims Presented By: Craig S. Stern, PharmD, MBA President Pro Pharma Pharmaceutical Consultants, Inc. October 21, 2014 Outline Rationale Scope list drug list Recommended
More informationCounties in the top and bottom two quintiles of both diabetes and obesity, Age-adjusted percentage of adults aged 20 years who are obese, 2007
Impact of Obesity on Medication Dosing John C. Williamson, PharmD, BCPS, AAHIVE Wake Forest University Baptist Medical Center Winston-Salem, NC Objectives Determine what constitutes the various forms of
More informationDEEP VEIN THROMBOSIS (DVT): TREATMENT
DEEP VEIN THROMBOSIS (DVT): TREATMENT OBJECTIVE: To provide an evidence-based approach to treatment of patients presenting with deep vein thrombosis (DVT). BACKGROUND: An estimated 45,000 patients in Canada
More informationDavid Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care
David Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care Geriatrics Clinic- Providence VAMC VA Grand Rounds
More informationEdoxaban for the treatment and prevention of venous thromboembolism (DVT or PE) or stroke prevention in non-valvular AF
Edoxaban for the treatment and prevention of venous thromboembolism (DVT or PE) or stroke prevention in non-valvular AF Traffic light classification- Amber 2 specialist initiation / recommendation Information
More informationHigh alert medicines
High alert medicines Dr Cristín Ryan, Royal College of Surgeons in Ireland Dr Ahmed Awaisu, College of Pharmacy, Qatar University Dr Bridget Javed, College of Pharmacy, Qatar University Dr Wessam El Kassem,
More informationReducing the risk of patient harm: A focus on opioids
Reducing the risk of patient harm: A focus on opioids New York State Partnership for Patients (NYSPFP) Initiative Regional Educational Session November 2013 1 Disclosure Matthew Fricker, Matthew Grissinger,
More informationPerformance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set
Unless indicated, the PINNACLE Registry measures are endorsed by the American College of Cardiology Foundation and the American Heart Association and may be used for purposes of health care insurance payer
More informationApril 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)
New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Nurse Practitioner Council New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) Peter Ryba, PharmD PMP Director
More informationChapter / Section / Drug
2 Cardiovascular System 2.1 Positive inotropic drugs Digoxin Digoxin specific antibody ( DigiFab ) 2.2 Diuretics 2.2.1 Thiazides and related diuretics Indapamide (1 st Line) Bendroflumethiazide Metolazone
More informationChapter 2 ~ Cardiovascular system
Chapter 2 ~ Cardiovascular System: General Section 1 of 6 Chapter 2 ~ Cardiovascular system 2.1 Positive inotropic drugs 2.1.1 Cardiac glycosides DIGOXIN 2.2 Diuretics Elixir 50micrograms in 1ml Injection
More informationRefilling a Prescription with No Refills Remaining
................................................................................................... Refilling a Prescription with No Refills Remaining Pharmacy Technology Solutions May, 2013 Refilling
More informationADMIT DIABETIC KETOACIDOSIS (DKA) PLAN - Phase: Begin Immediately/Emergency Center
- Phase: Begin Immediately/Emergency Center Weight PHYSICIAN S Allergies Admit/Discharge/Transfer Patient Status Requested Location: MICU, Pt Status: Inpatient (LOS > 2 midnights) Requested Location: 5E
More informationChapter 2 is a general introduction to the drug administration
Chapter 2 Safe and Accurate Drug Administration Chapter Overview Chapter 2 is a general introduction to the drug administration process. It introduces the student to the role of the person who administers
More informationIntensive Insulin in the Intensive Care Unit
TABLE OF CONTENTS Introduction to Intensive Insulin in Adult Critical Care Patients - UIMCC Guideline for Insulin Infusion in Adult ICU Patients - P&T Committee Formulary Action Intensive Insulin in the
More informationTools for Targeting High Risk Patients in Your Practice. Statement of Disclosure
Tools for Targeting High Risk Patients in Your Practice Joseph Vande Griend, PharmD, BCPS, CGP Assistant Professor, University of Colorado Departments of Clinical Pharmacy and Family Medicine Skaggs School
More informationUtilizing Automated Adverse Event Detection
Utilizing Automated Adverse Event Detection David C Stockwell, MD, MBA Executive Director of Improvement Science Medical Director of Patient Safety and Pediatric ICU Children s National Medical Center
More informationCost and Prevalence of A fib. Atrial Fibrillation: Guideline Directed Treatment. Prevalence of A Fib. Risk Factors for A Fib. Risk Factors for A Fib
Atrial Fibrillation: Guideline Directed Treatment Melissa Wendell, FNP-C, MSN Heart Failure - Lead Nurse Practitioner, Aspirus Wausau Hospital and Aspirus Cardiology Cost and Prevalence of A fib 33.5 million
More informationCORLANOR (ivabradine) oral tablet
CORLANOR (ivabradine) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage
More informationPharmacodynamics. Other Drug Reactions
Pharmacodynamics Ok. Now the drug has been re-absorbed, and now it is finally where we want it to go. It s going to go to the heart, the eye, or whatever our target organ may be. Now, once we get there,
More informationHigh Alert Medications: Reducing Patient Harm. Tennessee Center for Patient Safety Regional Meetings 2017 Brian D. Esters, PharmD, CPPS
High Alert Medications: Reducing Patient Harm Tennessee Center for Patient Safety Regional Meetings 2017 Brian D. Esters, PharmD, CPPS Learning Objectives Define High-Alert Medications Identify potential
More informationAnticoagulation Therapy in LTC
Anticoagulation Therapy in LTC By: Cynthia Leung, RPh, BScPhm, PharmD. Clinical Consultant Pharmacist MediSystem Pharmacy Jun 11, 2013 Agenda Stroke and Bleeding Risk Assessment Review of Oral Anticoagulation
More information5/8/2017. Clinical Pharmacy Specialist Division of Kidney Disease and Hypertension
Clinical Pharmacy Specialist Division of Kidney Disease and Hypertension Clinical Assistant Professor Adjunct Clinical Associate Professor Pharmacy Practice 1 http://ed.ted.com/lessons/how-do-your-kidneys-work-emma-bryce.
More information-DVT and PE Reduction Strategy in AWR- Can We Win? Luciano Tastaldi, MD
-DVT and PE Reduction Strategy in AWR- Can We Win? Luciano Tastaldi, MD Summary of the Project Objectives Present Numbers Evolution Challenges of Implementation Discuss Future Directions -Problem at CCF-
More informationPLEASE PRINT PLEASE CHECK THE BOX AFTER THE PHONE NUMBER THAT YOU WANT AS YOUR PREFERRED NUMBER
NORTHERN VIRGINIA CENTER FOR ARTHRITIS PLEASE PRINT PATIENT REGISTRATION Patient s Name: DOB: Sex: Address: PLEASE CHECK THE BOX AFTER THE PHONE NUMBER THAT YOU WANT AS YOUR PREFERRED NUMBER Home#( ) [
More informationPolypharmacy: So Many Drugs, So Little Time. Shannon O. Smith, MD General Internal Medicine Conference
Polypharmacy: So Many Drugs, So Little Time Shannon O. Smith, MD General Internal Medicine Conference Objectives 1. Recognize polypharmacy and what it means to your patients 2. Fix it. Patient Susie Q
More informationBack to Basics: The Basics of Medication Monitoring
DIAMOND PHARMACY SERVICES Back to Basics: The Basics of Medication Monitoring Presented by: Dr. Deborah Milito, Pharm. D., CGP. Director of Clinical and Consultant Services Skilled Division Annual Educational
More informationManaging Perioperative Anticoagulation. Edie Shen MD
Managing Perioperative Anticoagulation Edie Shen MD Anticoagulation VKA Warfarin (Coumadin) DOACs Direct Thrombin Inhibitor Dabigatran (Pradaxa) Factor Xa Inhibitor Rivaroxaban(Xarelto) Apixaban(Eliquis)
More information